Celldex Therapeutics, Inc

CLDX XNAS • IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

2.3B

Short interest (May 15)

9.1%

Net Short (Jun 03 ): -0.1%

Borrow Fee

0.32%

↑ 2.6%

Available Shares

900K

↓ 39.0%

Price Chart

Company Overview

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Company Info

Exchange: NASDAQ

Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

CIK: 0000744218

Asset Type: CS

Market Data

Market Cap: $2,268,420,880

Employees: 198

Status: Active

Short Interest

Current Borrow Fee 0.32%

Range: 0.27% - 0.32%

Available Shares 900K

Range: 750K - 850K

Recent Changes

Fee Change: ↑ 5.0%

Available Change: ↓ 10.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime